Merck & Co., Inc. (NYSE: MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted the company’s strategic planning for when Keytruda loses patent protection ...
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 12th Edition of their annual conference, "Merck Foundation Africa Asia Luminary", in partnership with the Government of The ...
We came across a bullish thesis on Merck & Co., Inc. on Darius Dark Investing’s Substack. In this article, we will summarize ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...
ORLANDO, FL / ACCESS Newswire / November 14, 2025 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today congratulated its ...
Early and sustained ctDNA clearance in early breast cancer treated with neoadjuvant HER2-targeted therapy tracks closely with pathologic complete response to treatment and 3-year outcomes.
A new study provides more evidence that many patients with early-stage breast cancer may avoid sentinel lymph node surgery ...
On paper, cultivated meat looks like a no-brainer. Unlike plant- or fungi-based options, it has the allure of “real” meat ...
Ability Biotherapeutics, a biotechnology company advancing logic-gated antibody therapies for cancer and autoimmune diseases, ...
MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback